BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 95 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $147 | -64.2% | 22 | 0.0% | 0.00% | – |
| Q1 2023 | $411 | -79.4% | 22 | -77.1% | 0.00% | – |
| Q1 2022 | $2,000 | -96.7% | 96 | -95.2% | 0.00% | -100.0% |
| Q3 2021 | $61,000 | +306.7% | 2,000 | +300.0% | 0.02% | +433.3% |
| Q2 2021 | $15,000 | -54.5% | 500 | -34.4% | 0.00% | -57.1% |
| Q1 2021 | $33,000 | +266.7% | 762 | +314.1% | 0.01% | +250.0% |
| Q4 2020 | $9,000 | -89.7% | 184 | -90.8% | 0.00% | -91.7% |
| Q3 2020 | $87,000 | – | 2,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 430,000 | $19,866,000 | 1.70% |
| APIS CAPITAL ADVISORS, LLC | 20,000 | $924,000 | 0.89% |
| Avidity Partners Management LP | 547,000 | $25,271,000 | 0.82% |
| Knoll Capital Management, LLC | 20,000 | $924,000 | 0.63% |
| Artemis Investment Management LLP | 1,013,448 | $46,839,000 | 0.49% |
| AlphaCentric Advisors LLC | 25,000 | $1,155,000 | 0.48% |
| First Light Asset Management, LLC | 94,202 | $4,352,000 | 0.32% |
| Ikarian Capital, LLC | 150,000 | $6,930,000 | 0.31% |
| Longitude (Cayman) Ltd. | 8,000 | $370,000 | 0.18% |
| AllSquare Wealth Management LLC | 5,490 | $254,000 | 0.17% |